Clinical Trials Logo
  1. Home
  2. Scalp Psoriasis
  3. NCT01914627

Parallel Group Trial to Evaluate the Efficacy and Safety of Loion® Compared to 10% Salicylic Acid in Patients With Chronic Psoriasis Capitis

Scalp Psoriasis Clinical Trial

Official title:
A Single-centre Randomised, Active-controlled, Observer-blinded, Parallel Group Trial to Evaluate the Efficacy and Safety of a Topical Dimeticone Formulation (Loion®) Compared to 10% Salicylic Acid in the Removal of Scaling in Patients With Chronic Psoriasis Capitis

Clinical Trial Summary

The study will be conducted to evaluate the efficacy and safety of a topical dimeticone formulation (Loion®) compared to 10% salicylic acid in octyl-dodecanol with 15% Macrogol-4-laurylether for the removal of scaling in patients with chronic psoriasis capitis (scalp psoriasis).

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01914627
Study type Interventional
Source G. Pohl-Boskamp GmbH & Co. KG
Contact
Status Completed
Phase Phase 2
Start date August 2013
Completion date January 2014
View Details
See also
  Status Clinical Trial Phase
Completed NCT00400725 - Maintenance Effect of Clobex Shampoo on Participants With Moderate to Severe Scalp Psoriasis Phase 3
Completed NCT01195831 - Efficacy and Safety of Xamiol® Gel Compared to Calcipotriol Scalp Solution in Patients With Scalp Psoriasis Phase 3
Completed NCT03880357 - To Evaluate the Therapeutic Equivalence and Safety in Treatment of Scalp Psoriasis Phase 1
Completed NCT03331523 - To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Suspension, 0.005%/0.064%, in the Treatment of Scalp Psoriasis Phase 3
Completed NCT04801433 - Evaluate the Efficacy and Safety of Boroda Supramolecular Active Zinc in the Treatment of Scalp Psoriasis N/A
Completed NCT01120223 - Safety and Efficacy of LEO 80185 Gel in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis Phase 2
Completed NCT03897088 - Efficacy and Safety of Tildrakizumab in the Treatment of Scalp Psoriasis Phase 3
Completed NCT02932462 - Study to Evaluate Efficacy and Safety of the Topical Product in Patients With Mild to Severe Scalp Psoriasis Phase 3
Completed NCT02933866 - Phase III Clinical Study in Patients With Mild to Severe Scalp Psoriasis Phase 3
Completed NCT05872256 - A Demonstration of the Hair and Scalp Benefits of Duobrii in Scalp Psoriasis Phase 4
Active, not recruiting NCT05272150 - Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp Psoriasis Phase 3
Completed NCT02933502 - Safety Study in Patients With Scalp Psoriasis Suppression Following Maximal Use Treatment With Topical Product Phase 2
Completed NCT01052467 - Topical Treatment of Scalp Psoriasis With the Fixed Combination of Calcipotriol and Betamethason (Xamiol® Gel) N/A
Completed NCT04243486 - A Study of the Safety and Efficacy of UHE-105 Shampoo in Subjects With Scalp Psoriasis Phase 2
Recruiting NCT02749656 - Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy®) in the Treatment of Scalp Psoriasis Phase 3
Completed NCT02078297 - IL-17 Role in Variants of Psoriasis N/A
Completed NCT00438399 - Subject Preference for Scalp Psoriasis Treatment Phase 3
Completed NCT05028582 - Topical Roflumilast to Treat Scalp and Body Psoriasis (ARRECTOR) Phase 3
Not yet recruiting NCT01558310 - A Study to Evaluate the Effectiveness of STELARA ™ (USTEKINUMAB) in the Treatment of Scalp Psoriasis Phase 4
Recruiting NCT05969223 - Study to Assess the Safety and Efficacy of Subcutaneously Injected Risankizumab in Adult Participants With Genital or Scalp Psoriasis Phase 4